Literature DB >> 5467975

Plasma renin activity and levodopa in Parkinson's disease.

A M Michelakis, D Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5467975

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Autonomic Nervous System Dysfunction in Parkinson's Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Mervat Wahba; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC).

Authors:  H Allain; J Van den Driessche; D Bentue-Ferrer; J M Reymann; D Pape; M Madigand
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

Review 5.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.

Authors:  A Rappelli; N Glorioso; R Tedde; P Dessi'-Fulgheri; F Monaco
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-10       Impact factor: 10.154

7.  An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion.

Authors:  Emily M Garland; Tericka S Cesar; Suzanna Lonce; Marcus C Ferguson; David Robertson
Journal:  Am J Clin Nutr       Date:  2013-04-03       Impact factor: 7.045

8.  Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1972-06-10       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.